MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration
Expired
The competition has expired without a winner being announced.
- Deadline
- 14. okt.Expired
- Award
- Pris
Brief
The European Union Drugs Agency (EUDA) needs services for a "MASSIVE – Metabolite Analysis System Supporting In-depth Validation and Exploration" contract over 3 years, with a maximum total value of 500,000 EUR. The objective is to reinforce collective capacity across the EU to interpret toxicological findings and improve the detection, identification, and timely reporting of exposure to New Psychoactive Substances (NPS) and other illicit drugs by generating robust metabolic, pharmacological, and analytical data and consolidating these into a centralised, accessible EU database. The contract will be awarded based on quality and price.
Forskning og miljøovervåking
Previous winners
Who are you up against?
The suppliers who have won similar contracts at European Union Drugs Agency
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Vennligst se anskaffelsesdokumentene for detaljer.
Source
No source found in the documents. Check the weight against the tender documents.
Description
Vennligst se anskaffelsesdokumentene for detaljer.
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
Regulation (EU) 2023/1322, which establishes the European Union Drugs Agency (EUDA), strengthens the Union’s preparedness for, and response to, drug-related health and security challenges. Article 15 in particular provides for a dedicated network of forensic and toxicology laboratories to enhance analytical capacity, harmonise methods, support quality assurance and facilitate the exchange of data and expertise across Member States. This strengthens and supports the timely detection, assessment and response to drug-related risks. Within this policy context, systematic investigation of drug metabolism is a cornerstone of clinical and forensic toxicology. Overall, the objective of this contract is to reinforce collective capacity across the EU to interpret toxicological findings and, critically, to improve the detection, identification, and timely reporting of exposure to NPS and other illicit drugs. By generating robust metabolic, pharmacological, and analytical data, and by consolidating these outputs into a centralised, accessible EU database, the project aims to strengthen timely reporting, harmonise practices, and ensure that toxicological evidence can be translated more effectively into monitoring, early warning, and public health responses to emerging NPS threats.
Contact
infoprocurement@euda.europa.eu- CompetitionType
- 73200000Main codeResearch and development consultancy services